ES551843A0 - Procedimiento para preparar dihidropiridinas. - Google Patents

Procedimiento para preparar dihidropiridinas.

Info

Publication number
ES551843A0
ES551843A0 ES551843A ES551843A ES551843A0 ES 551843 A0 ES551843 A0 ES 551843A0 ES 551843 A ES551843 A ES 551843A ES 551843 A ES551843 A ES 551843A ES 551843 A0 ES551843 A0 ES 551843A0
Authority
ES
Spain
Prior art keywords
procedure
preparing dihydropyridines
dihydropyridines
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551843A
Other languages
English (en)
Other versions
ES8802026A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES8802026A1 publication Critical patent/ES8802026A1/es
Publication of ES551843A0 publication Critical patent/ES551843A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES551843A 1985-02-11 1986-02-11 Procedimiento para preparar dihidropiridinas. Expired ES8802026A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503424A GB8503424D0 (en) 1985-02-11 1985-02-11 Heterocyclic derivatives

Publications (2)

Publication Number Publication Date
ES8802026A1 ES8802026A1 (es) 1988-03-16
ES551843A0 true ES551843A0 (es) 1988-03-16

Family

ID=10574269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551843A Expired ES8802026A1 (es) 1985-02-11 1986-02-11 Procedimiento para preparar dihidropiridinas.

Country Status (14)

Country Link
EP (1) EP0194750A1 (es)
JP (1) JPS61246162A (es)
AU (2) AU5397486A (es)
DK (1) DK66086A (es)
ES (1) ES8802026A1 (es)
FI (1) FI860622A (es)
GB (1) GB8503424D0 (es)
GR (1) GR860382B (es)
HU (1) HUT40416A (es)
IL (1) IL77849A0 (es)
NO (1) NO860471L (es)
PT (1) PT82021B (es)
WO (1) WO1986004581A1 (es)
ZA (1) ZA86997B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
EP0254682A1 (de) * 1986-07-22 1988-01-27 Ciba-Geigy Ag Neue Phenoxyaliphatylphenylenoxyalkylester und -amide
EP0276552A1 (en) * 1986-12-08 1988-08-03 Yamanouchi Pharmaceutical Co. Ltd. 1,4-dihydropyridine derivatives and their production
IT1229118B (it) * 1988-07-29 1991-07-22 Simes Composti attivi sul sistema cardiovascolare che presentano sia la struttura dei beta-bloccanti sia una porzione calcio-antagonista
EP0352863A3 (en) * 1988-07-29 1990-08-22 ZAMBON GROUP S.p.A. 1,4-dihydropyridine dicarboxylic acid derivatives
US5468746A (en) * 1988-07-29 1995-11-21 Zambon Group S.P.A. Compounds active on the cardiovascular system
KR940005016B1 (ko) * 1990-11-30 1994-06-09 후지레비오 가부시끼가이샤 1,4-디히드로피리딘 유도체 및 그의 제조방법
DE4131346A1 (de) * 1991-09-20 1993-03-25 Bayer Ag Indolsulfonamid substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
AU4586093A (en) * 1992-07-28 1994-02-14 Daicel Chemical Industries Ltd. Antihypertensive 1,4-dihydropyridine derivatives and process for their preparation
NL1012886C1 (nl) 1999-08-23 2001-02-26 Rephartox 1,4-Dihydropyridine-5-carbonzuuresterderivaten en werkwijze voor de bereiding ervan.
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
CN101215258A (zh) * 2008-01-21 2008-07-09 中国药科大学 二氢吡啶类钙拮抗剂化合物及其制备方法与医药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
ES8802026A1 (es) 1988-03-16
NO860471L (no) 1986-08-12
AU5339386A (en) 1986-08-14
ZA86997B (en) 1986-12-30
PT82021A (en) 1986-03-01
WO1986004581A1 (en) 1986-08-14
EP0194750A1 (en) 1986-09-17
FI860622A0 (fi) 1986-02-11
HUT40416A (en) 1986-12-28
IL77849A0 (en) 1986-08-31
AU5397486A (en) 1986-08-26
DK66086D0 (da) 1986-02-11
FI860622A (fi) 1986-08-12
DK66086A (da) 1986-08-12
PT82021B (en) 1987-12-16
GR860382B (en) 1986-05-29
GB8503424D0 (en) 1985-03-13
JPS61246162A (ja) 1986-11-01

Similar Documents

Publication Publication Date Title
ES553989A0 (es) Procedimiento para preparar 2,2,6,6-tetraalquil-4-piperidilaminas
ES557241A0 (es) Procedimiento para preparar nuevos 2-aril-imidazoles
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
ES551113A0 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
MX9100033A (es) Procedimiento para preparar isoxazoles.
ES550730A0 (es) Procedimiento para preparar poliesterpolioles
NO861114L (no) Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater.
ES551807A0 (es) Procedimiento para preparar piridinil acilhidrazonas
ES555546A0 (es) Procedimiento para preparar derivados de cinalina.
ES551843A0 (es) Procedimiento para preparar dihidropiridinas.
ES557193A0 (es) Procedimiento para preparar polipeptidos.
ES555561A0 (es) Procedimiento para preparar celalosporinas
ES549975A0 (es) Procedimiento para preparar n-formil-&-aspartil fenilalanina
MX160612A (es) Procedimiento para preparar 3-carbonil-1-aminoalquil-1h-indoles
ES548237A0 (es) Procedimiento para preparar n6-bicicloadenosinas
ES544622A0 (es) Procedimiento para preparar l-fenilalamina
ES551845A0 (es) Procedimiento para preparar dihidropiridinas.
ES551844A0 (es) Procedimiento para preparar dihidropiridinas.
ES551847A0 (es) Procedimiento para preparar dihidropiridinas.
ES556082A0 (es) Procedimiento para preparar derivados de 1,4-dihidropiridina con actividad cardiovascular
ES544074A0 (es) Procedimiento para preparar naftoxacinas
KR860005812A (ko) 4,4-디알킬-2-아제티디논의 제조 방법
ES557615A0 (es) Procedimiento para preparar disulfuros heterociclicos
MX162329A (es) Procedimiento para preparar acilhidrazonas sulfeniladas